2022 Archived Content


Missed Immuno-Oncology Summit Europe this Year?

Access Event Platform

Missed this year's event? Access content across all of this year's programs On-Demand. At your convenience, access archived presentations for On-Demand learning, from anywhere, at any time.




About the Immuno-Oncology Summit Europe

CHI’s Sixth Annual Immuno-Oncology Summit Europe returns to London’s Canary Wharf for three packed days of science and technology, discussion and networking, with coverage of recent advances in the development of promising immuno-oncology treatments. The event is comprised of three conference programs that cover therapeutic categories; T-Cell and related Cellular Therapeutics, Bi-specific Antibodies and Therapies targeting the Tumour Microenvironment, while a fourth program covers strategies for Therapeutic Development, including Predictive Biomarkers, Preclinical studies and Translational Studies. Clinical results and combination therapies will also be highlighted.




Plenary Keynote Speakers

Dario Neri, PhD

Dario Neri, PhD
Philogen

Sergio A. Quezada, PhD

Sergio A. Quezada, PhD
University College London

Claire Roddie, PhD

Claire Roddie, PhD
UCL Cancer Institute

Roy Baynes, MD, PhD

Roy Baynes, MD, PhD
Merck, Sharp, and Dohme


Featured Speakers

Ruud de Wildt, Ph.D.

Ruud de Wildt, Ph.D.
GSK

Sophia N. Karagiannis, BA, MS, PhD

Sophia N. Karagiannis, BA, MS, PhD
King's College London

Marina Bacac, PhD

Marina Bacac, PhD
Roche Innovation Center Zurich

Sam Hanash, MD

Sam Hanash, MD
Anderson

Richard Stebbings

Richard Stebbings
AstraZeneca

Christine Trumpfheller

Christine Trumpfheller
Roche Innovation Centre

Francesco Marincola, MD

Francesco Marincola, MD
Kite Pharma

Andrew Sewell, PhD

Andrew Sewell, PhD
Cardiff University School of Medicine

Howard Goodall, MBChB

Howard Goodall, MBChB
Immunocore

Zhen Su

Zhen Su
Marengo Therapeutics

Robert Wilkinson

Robert Wilkinson
AstraZeneca

Eric Smith

Eric Smith
Regeneron